MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Impaired ocular tracking in idiopathic REM sleep behavior disorder is associated with gray matter alterations

    L. Zhou, J. Chen, C. Jiang, X. Zuo, L. Li, J. Liu (Shanghai, China)

    Objective: Using an established 15-min ocular-tracking task and structural MRI scanning, we examined the ocular tracking ability in iRBD patients and its anatomical correlates. Background:…
  • MDS Virtual Congress 2021

    Risk factors for the onset of dyskinesia in patients with Parkinson’s disease exhibiting wearing-off phenomena: A 1-year observational study in Japan (J-FIRST)

    T. Mishima, SW. Chiu, H. Saiki, T. Yamaguchi, Y. Shimo, T. Maeda, H. Watanabe, K. Kashihara, M. Nomoto, N. Hattori, Y. Tsuboi (Fukuoka, Japan)

    Objective: To investigate the risk factors for the onset of dyskinesia in patients with Parkinson's disease (PD) exhibiting wearing-off phenomena. Background: Dyskinesia occurs during long-term…
  • MDS Virtual Congress 2021

    Cognitive assessment of Parkinson’s Disease patients in a Northeast Brazilian population: Current Challenges

    J. Bonfadini, D. Lima, A. Carneiro, J. Luna, A. Damasceno, P. Braga-Neto (Fortaleza, Brazil)

    Objective: To evaluate the influence of education level in the Mini-Mental Status Examination (MMSE) score in Parkinson’s Disease (PD) patients in a northeast Brazilian sample.…
  • MDS Virtual Congress 2021

    Effects of levodopa on cognitive functions in Parkinson’s disease

    S. Ismailova, S. Prokopenko (Krasnoyarsk, Russian Federation)

    Objective: To assess the dynamics of cognitive functions (CF) under the influence of levodopa in PD patients Background: Our research is devoted to an urgent problem-the…
  • MDS Virtual Congress 2021

    Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Change

    X. Ren, J. Lin, G. Stebbins, C. Goetz, S. Luo (Foster City, CA, USA)

    Objective: To develop a prognostic model using multiple longitudinal measures to predict temporal clinical progression in early PD. Background: Predicting time to Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Digenic R1441G-LRRK2 and Parkin mutations in Parkinson’s Disease: first clinicopathological case report.

    D. Campo-Caballero, A. Vinagre-Aragón, JF. Martí-Massó, A. Bergareche, A. Gorostidi, R. Ruiz-Onandi, J. Rodríguez-Antigüedad, J. Equiza, P. Iruzubieta-Agudo, I. Albajar, N. Sulibarria, J. Ruiz-Martinez (San Sebastián, Spain)

    Objective: To report a clinicopathological case of digenic PD with R1441G- LRRK2 and PRKN mutations. Background: Digenic inheritance of R1441G-LRRK2 and PRKN mutation is extremely…
  • MDS Virtual Congress 2021

    Building a Global Parkinson’s Genetics Program (GP2): Clinical Cohorts Integration Working Group

    J. Joubert, M. Tan, T. Antar, A. Martinez-Carrasco, H. Iwaki, H. Morris, GP2. Genetics Program (London, United Kingdom)

    Objective: To recruit Parkinson's Disease (PD) cohorts across the world for the global Parkinson's Genetics Program (GP2, http://gp2.org/), harmonise clinical data across cohorts for joint…
  • MDS Virtual Congress 2021

    Clinical and genetic analysis of psychosis in Parkinson’s disease

    B. Radojević, N. Dragašević, A. Milovanović, V. Dobričić, M. Svetel, I. Petrović, M. Savić, I. Jančić, D. Stanisavljević, A. Marjanović, M. Branković, V. Kostić (Belgrade, Serbia)

    Objective: This study aimed to examine the association of seven selected polymorphisms of DRD2, ANKK1, COMT and DAT genes with Parkinson’s disease psychosis (PDP) onset.…
  • MDS Virtual Congress 2021

    Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: a Surgicogenomic Approach

    N. Visanji, M. Ghani, E. Yu, E. Kakhki, C. Sato, D. Moreno, T. Naranian, YY. Poon, M. Abdollahi, M. Naghibzadeh, R. Rajalingam, A. Lozano, S. Kalia, M. Hodaie, M. Cohn, M. Statucka, A. Boutet, G. Elias, J. Germann, R. Munhoz, A. Lang, Z. Gan-Or, E. Rogaeva, A. Fasano (Toronto, Canada)

    Objective: We aimed to identify genetic variants associated with clinical heterogeneity in deep brain stimulation outcome of Parkinson’s Disease patients with an overall objective of…
  • MDS Virtual Congress 2021

    Correlating LRRK2 activation status in peripheral blood to urine BMPs in monogenic and idiopathic Parkinson’s disease

    S. Gomes, A. Garrido, F. Tonelli, E. Tolosa, M. Marti, D. Anderson, N. Pratuseviciute, F. Hsieh, T. Bruecke, T. Koenig, C. Hotzy, J. Ruiz-Martínez, A. Bergareche-Yarza, E. Mondragón Rezola, A. Vinagre Aragón, I. Croitoru, A. Gorostidi Pagola, L. Paternain Markinez, F. Valldeoriola, K. Merchant, S. Padmanabhan, A. Zimprich, D. Alessi, E. Sammler (Dundee, United Kingdom)

    Objective: The greatest unmet need in Parkinson’s disease (PD) are disease-modifying treatments. The discovery of monogenic forms of PD has provided invaluable insights into pathomechanisms…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley